Hasan, SS, Capstick, T, Zaidi, STR et al. (2 more authors) (2020) Use of corticosteroids in asthma and COPD patients with or without COVID-19. Respiratory Medicine, 170. 106045. ISSN 0954-6111
Abstract
The potential detrimental effects of steroids on the immune system to fight viral infections had always been a concern for patients on long term steroids in chronic conditions. A recent warning from WHO on systemic corticosteroid use amid COVID-19 raised suspicion among public and healthcare professionals regarding the safety of steroid use during the SARS-CoV-2 pandemic. The corticosteroids (inhaled and oral) are commonly prescribed in the management of asthma and COPD patients and any unsolicited changes in medications use may lead to potentially severe exacerbations and may risk patient lives. This article provides a critical review of clinical evidence and offers a detailed discussion on the safety and efficacy of corticosteroids in asthma and COPD patients, both with and without COVID-19.
Metadata
| Authors/Creators: |
|
|---|---|
| Keywords: | Asthma; Chronic obstructive pulmonary disease; Coronavirus disease 2019; Inhaled corticosteroid; Oral corticosteroid |
| Dates: |
|
| Institution: | The University of Leeds |
| Academic Units: | The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Healthcare (Leeds) > Pharmacy (Leeds) |
| Depositing User: | Symplectic Publications |
| Date Deposited: | 24 Sep 2020 09:44 |
| Last Modified: | 24 Sep 2020 09:44 |
| Status: | Published |
| Publisher: | Elsevier |
| Identification Number: | https://doi.org/10.1016/j.rmed.2020.106045 |
CORE (COnnecting REpositories)
CORE (COnnecting REpositories)